NCT00273351View on ClinicalTrials.gov

Imaging and Genetic Biomarkers of Parkinson Disease (PD) Onset and Progression in High-risk Families

PHASE2CompletedINTERVENTIONAL

Enrollment

62

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

January 31, 2008

Study Completion Date

January 31, 2008

Conditions

Parkinson DiseaseParkinsonian Syndrome

Interventions

DRUG

[123I]B-CIT

Subjects will receive up to 6 mCi of \[123I\] B-CIT injected intravenously

Trial Locations (1)

06510

Institute for Neurodegenerative Disorders, New Haven

Sponsors

Collaborators (1)

Molecular NeuroImaging

All Listed Sponsors

collaborator

United States Department of Defense

FED

collaborator

Molecular NeuroImaging

OTHER

lead

Institute for Neurodegenerative Disorders

OTHER